BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30705403)

  • 1. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
    Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C; Shi J; Li Q; Li Z; Lou C; Zhao Q; Zhu Y; Zhan F; Lian J; Wang B; Guan X; Fang L; Li Z; Wang Y; Zhou B; Yao Y; Zhang Y
    Clin Sci (Lond); 2019 Mar; 133(5):645-663. PubMed ID: 30782607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
    Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
    Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
    Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis.
    Reichert M; Takano S; von Burstin J; Kim SB; Lee JS; Ihida-Stansbury K; Hahn C; Heeg S; Schneider G; Rhim AD; Stanger BZ; Rustgi AK
    Genes Dev; 2013 Feb; 27(3):288-300. PubMed ID: 23355395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.
    Zhu J; Zhao J; Luo C; Zhu Z; Peng X; Zhu X; Lin K; Bu F; Zhang W; Li Q; Wang K; Hu Z; Yu X; Chen L; Yuan R
    Cell Death Dis; 2022 May; 13(5):497. PubMed ID: 35614040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
    Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
    Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage.
    El Hassouni B; Mantini G; Immordino B; Peters GJ; Giovannetti E
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
    Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
    Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.
    Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I
    Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
    Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
    Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
    Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
    Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.
    Edderkaoui M; Chheda C; Soufi B; Zayou F; Hu RW; Ramanujan VK; Pan X; Boros LG; Tajbakhsh J; Madhav A; Bhowmick NA; Wang Q; Lewis M; Tuli R; Habtezion A; Murali R; Pandol SJ
    Gastroenterology; 2018 Dec; 155(6):1985-1998.e5. PubMed ID: 30144430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
    Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1.
    Jingyang Z; Jinhui C; Lu X; Weizhong Y; Yunjiu L; Haihong W; Wuyuan Z
    Curr Pharm Biotechnol; 2021; 22(8):1106-1113. PubMed ID: 32942974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
    Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
    Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
    Karelia DN; Kim S; K Pandey M; Plano D; Amin S; Lu J; Sharma AK
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRRX1/FOXM1 reduces gemcitabin-induced cytotoxicity by regulating autophagy in bladder cancer.
    Huang X; Huang W; Wu K; Lin Q; Chen G
    Transl Androl Urol; 2022 Aug; 11(8):1116-1129. PubMed ID: 36092834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.